MOBILE   |  REGISTER   |   LOGIN   |   HELP
HOME  |  ABOUT US  |  BLOGGERS  |  BLOGS  |  MESSAGES  |  VIDEO  |  QUIZZES  |  LIBRARY  |  WEBINARS
A Gated Community for Oncology Nurses and
Cancer Care Teams | More Info
Breast   |   Prostate   |   Lung   |   Hematology   |   Skin   |   Gastrointestinal   |   Genitourinary   |   Head / Neck   |   Brain   |   Gynecological   |   Sarcoma   |   Thyroid
Career  |  Exercise  |  Nutrition  |  Recipes  |  Survivorship  |  Symptom Management  |  Emergencies  |  Side Effects  |  Pediatrics  |  Complementary Therapies

Date: Thursday, July 12, 2012
Time: 9:00 a.m. PT / 12:00 p.m. ET
Overview:

Presented by Krista M. Rubin, MS, FNP-BC, highlights include:

  • Identifying common presentations of primary melanomas
  • Discussion about the importance of correct staging of primary melanomas 
  • Learning about the current standards for treatment of early and later stage melanoma
  • Discussing the novel and investigation approaches currently being explored in advanced melanoma
  • A question and answer period following the presentation

Register for this informative free webinar now!

Melanoma is the most serious form of skin cancer and the incidence is increasing at alarming rates with one in 50 persons estimated to be diagnosed with melanoma in 2012. When diagnosed at an early stage, most melanomas are curable; however advanced melanoma remains a devastating and typically deadly disease. Up until very recently, five year survival rates for inoperable and/or distant metastatic melanoma were under 10 percent. 

Prompt diagnosis and proper staging of primary melanomas is cornerstone to optimizing outcomes. So called “standard treatments” for high risk and advanced melanoma remain controversial, and the landscape for advanced disease continues to evolve.



Webinar Archive Registration

To register for this webinar, please complete the form below. Take care to provide all required information (indicated in red). Press Register to complete your registration. If you have already registered for our site or for one of our webinars, you may login to register without re-entering your information.

Sign up for our newsletters.
TheONC Now
The best advice, opinions, and conversations from our oncology nurse community. The easiest way to stay up to date on how to make your patients and practice better.
Are you a health professional who collaborates as part of the cancer care team or provides health guidance to cancer patients? *
Email Address *
Username * - Choose carefully, your Username will identify you on our message boards. It cannot be changed after you register!
Create a Password *
Re-enter Password *
First Name *
Last Name *
Job Title (Optional)
Employer / Company Name (optional)
Country *
Zip/Postal Code *
Occupation: *
Specialty: *
If you selected "Other" above, please clarify your answer.
Please indicate your agreement to the Terms of Use. *
I agree to the Terms of Service.
Terms of Privacy Statement here.
Webinar Series
Tuesday, October 29, 2013 12:00 PM EDT
Archived

Presented by Ellen T. Matloff, MS, CGC , this webinar will highlight:

  • How to determine which patients require genetic counseling
  • How to help prepare your patients for the genetic counseling process
  • Testing options that are now available
  • How you can utilize this data in managing your patients and their family members

Participants will also be able to ask questions during a live question and answer period with speaker Ellen T. Matloff, MS, CGC .

Wednesday, August 28, 2013 12:00 PM EDT
Wednesday, June 26, 2013 12:00 PM EDT
Wednesday, April 10, 2013 12:00 PM EDT
Readerboards
Have a question or topic but don't want to write a blog? Post it on our readerboards and get feedback from the community!
Patriotacp on Enhance your Business through Excellent Website Promotion
Patriotacp on Enhance your Business through Excellent Website Promotion
Patriotacp on Enhance your Business through Excellent Website Promotion
FDA Approves Onivyde for Advanced Pancreatic Cancer
Marijke Vroomen Durning, RN,
10/27/2015  3
On October 22, 2015, the US Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection, Merrimack Pharmaceuticals, Inc.), in combination with fluorouracil ...
Like Us on Facebook
on Twitter
TheONC Twitter Feed
TheONC.org